For the long run, the agency needs to find better ways to assess the safety of drugs once they are on the market.

However, drug safety and efficacy beyond 1 year of total treatment have not been established.

Our comments focus on some issues relating to drug safety.

Those who work in the agency's office of drug safety get two-thirds less, which keeps most at home.

It expresses concern that the safety of new drugs might be called into question.

"There is no independent voice for drug safety in the United States."

Many countries have official bodies that monitor drug safety and reactions.

Once again, an agency badly in need of reform faces growing popular outrage over drug safety.

One of the more contentious issues related to drug safety is immunity from prosecution.

We need to better understand the safety of new antidiabetic drugs.